STO-CSCO Joint Symposium 2017

Continuing to build on the vibrant partnership of STO and CSCO, this symposium will be featured during the 20th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) from September 26 – 30, 2017.

Translated Articles

Read translations of selected articles targeting practice issues relevant to Chinese clinicians.

Browse All Topics

The Oncologist in China

Download a 2-page pdf overview of The Oncologist’s Clinical Trial Results section information.

Video Library

Watch the latest presentations from the STO First Advisory Council: LUNG CANCER: A Grand Challenge for Public Health & Education.

Past Meetings

Welcome to 'The Oncologist' in China

Recent Translated Articles from The Oncologist

Volume 22, Number 2, February 2017

Gastrointestinal Cancer

An Oncogenic ALK Fusion and an RRAS Mutation in KRAS Mutation‐Negative Pancreatic Ductal Adenocarcinoma
Yoko Shimada, Takashi Kohno, Hideki Ueno, Yoshinori Ino, Hideyuki Hayashi, Takashi Nakaoku, Yasunari Sakamoto, Shunsuke Kondo, Chigusa Morizane, Kazuaki Shimada, Takuji Okusaka, Nobuyoshi Hiraoka
The Oncologist 2017; 22:158-164; first published on February 6, 2017; doi:10.1634/theoncologist.2016-0194

Lung Cancer

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials
Xiaofei Wang, Xiaoyi Wang, Lydia Hodgson, Stephen L. George, Daniel J. Sargent, Nate R. Foster, Apar Kishor Ganti, Thomas E. Stinchcombe, Jeffrey Crawford, Robert Kratzke, Alex A. Adjei, Hedy L. Kindler, Everett E. Vokes, Herbert Pang
The Oncologist 2017; 22:189-198; first published on February 10, 2017; doi:10.1634/theoncologist.2016-0121

Volume 22, Number 1, January 2017

Global Health and Cancer

Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies
Jin Sheng, Ya‐Xiong Zhang, Xiao‐Bo He, Wen‐Feng Fang, Yun‐Peng Yang, Gui‐Nan Lin, Xuan Wu, Ning Li, Jing Zhang, Lin‐Zhu Zhai, Yuan‐Yuan Zhao, Yan Huang, Ning‐Ning Zhou, Hong‐Yun Zhao, Li Zhang
The Oncologist 2017; 22:53-60; first published on October 27, 2016; doi:10.1634/theoncologist.2016-0013

Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non‐Small Cell Lung Cancer
Zhong‐Yi Dong, Hao‐Ran Zhai, Qing‐Yi Hou, Jian Su, Si‐Yang Liu, Hong‐Hong Yan, Yang‐Si Li, Zhi‐Yong Chen, Wen‐Zhao Zhong, Yi‐Long Wu
The Oncologist 2017; 22:61-69; doi:10.1634/theoncologist.2016-0150

No front page content has been created yet.


The Oncologist and the Society for Translational Oncology (STO) partner with the Chinese Society of Clinical Oncology (中国抗癌协会临床肿瘤学协作专业委员会, CSCO) and the CSCO Foundation (中国临床肿瘤学会基金会) on educational initiatives that address critical health and cancer care issues in China. These efforts serve to foster communication between Chinese physicians and other leaders in oncology practice throughout the world.